General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 1401: Caseating necrosis most commonly occurs in

A. Brain
B. Liver
C. Kidney
D. Lung (Correct Answer)

Explanation: ***lung*** - **Caseating necrosis** is classically associated with **tuberculosis**, which primarily affects the lungs [1]. - It is characterized by the presence of **granulomatous inflammation**, often leading to the formation of cavities in pulmonary tissue. *Brain* - While certain infections can lead to necrosis in the brain, they typically do not present as **caseating necrosis**, which is specific to certain conditions like tuberculosis. - The brain may show **liquefactive necrosis** or other types of necrosis, rather than **caseation**. *liver* - The liver usually shows **macrovesicular steatosis** or **apoptosis** in conditions like hepatitis, not caseating necrosis. - **Granulomatous hepatitis** can occur, but it does not typically result in **caseating** type necrosis associated with lung pathology. *kidney* - The kidneys can experience necrosis from various causes, but caseating necrosis is not typical; they are more often involved in **focal segmental glomerulosclerosis** or **acute tubular necrosis**. - Chronic kidney conditions may involve granulomas, but they usually are not characterized by **caseation** similar to that seen in pulmonary tissue. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 55.

Question 1402: What is the definition of lipofuscin?

A. Wear and tear pigment (Correct Answer)
B. Fat deposits
C. Blood pigment
D. Form of calcification

Explanation: ***Wear and tear pigment*** - Lipofuscin is known as **wear and tear pigment** that accumulates in cells over time, especially in aging cells [1]. - It is a byproduct of **cellular lipid peroxidation** and protein degradation, indicative of oxidative stress [1]. *Form of calcification* - Not to be confused with calcification, lipofuscin is a **pigment** and not related to calcium deposition [1]. - Calcification usually occurs in response to tissue injury or necrosis, which differs fundamentally from lipofuscin accumulation. *Fat deposits* - Lipofuscin is made up of **an insoluble complex** and is not classified simply as fat or fat deposits [1]. - It is the result of the **degradation of cellular components**, rather than the accumulation of unutilized fats [1]. *Blood pigment* - Lipofuscin is not derived from **hemoglobin** or any blood components, distinguishing it from true blood pigments like **bilirubin**. - It is associated with **cellular aging** rather than with any specific blood function or metabolism [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 75-77.

Question 1403: What does Prussian blue staining specifically detect in histology?

A. Ferric iron (Correct Answer)
B. Ferrous iron
C. Glycogen
D. Lipids

Explanation: ***Ferric iron*** - The **Prussian blue reaction**, also known as Perls' stain, specifically identifies **ferric iron (Fe3+)** in tissue sections. - This stain is crucial for diagnosing conditions involving **iron overload**, such as hemochromatosis or hemosiderosis, by highlighting iron deposits as blue. *Ferrous iron* - The Prussian blue stain does **not react with ferrous iron (Fe2+)**; it specifically targets the ferric (oxidized) state of iron. - While ferrous iron is present in the body, it is not detected by this particular staining method for routine histological assessment of iron stores. *Glycogen* - **Glycogen** is a polysaccharide storage molecule and is typically stained using the **Periodic Acid-Schiff (PAS) stain**, which produces a magenta color. - Prussian blue staining is entirely unrelated to the detection of glycogen and would not highlight these molecules in tissue. *Lipids* - **Lipids** are fats and are typically stained with lipid-soluble dyes like **Oil Red O** or **Sudan Black**, especially in frozen sections to preserve their structure. - Prussian blue stain has no affinity for lipids and therefore cannot be used to detect them in histological samples.

Question 1404: Which of the following is not considered an example of excess tissue growth?

A. Granulation tissue (Correct Answer)
B. Neoplasia
C. Hyperplasia
D. Fibrosis

Explanation: ***Granulation tissue*** - Granulation tissue is a normal part of the healing process and does not represent an **excessive growth** of tissue [3]. - It consists mainly of **new connective tissue** and blood vessels formed during healing, rather than a pathological proliferation [3]. *Hyperplasia* - Hyperplasia is characterized by an **increase in the number** of cells in a tissue, leading to tissue enlargement [1][2]. - This process is often a response to a stimulus, such as hormonal changes or injury, indicating **excess tissue growth** [2]. *Neoplasia* - Neoplasia refers to the **abnormal proliferation** of cells, forming a neoplasm or tumor, which can be benign or malignant. - This is a clear example of **excess tissue growth**, as it involves uncontrolled cell division. *Fibrosis* - Fibrosis implies the formation of excess **fibrous connective tissue**, leading to a stiff or thickened tissue, signifying abnormal tissue growth [4]. - It often results from chronic inflammation or injury, again reflecting **excessive tissue** formation [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 87-88. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-87. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 105-106. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 111-112.

Question 1405: Fat necrosis is most commonly associated with which of the following?

A. Breast tissue
B. Omental fat
C. Retroperitoneal fat (Correct Answer)
D. None of the options

Explanation: ***Correct: Retroperitoneal fat*** - **Fat necrosis is most commonly associated with acute pancreatitis**, where activated pancreatic enzymes (lipases) leak into surrounding tissues and digest retroperitoneal and peripancreatic fat - This is termed **enzymatic fat necrosis** or **steatonecrosis**, characterized by the formation of **calcium soaps (saponification)** - a pathognomonic feature - Clinically presents with elevated amylase/lipase, severe epigastric pain radiating to the back, and **Cullen's sign** (periumbilical ecchymosis) or **Grey Turner's sign** (flank ecchymosis) in severe cases - This is the **classic and most frequently cited example** of fat necrosis in pathology textbooks and medical education *Incorrect: Breast tissue* - Fat necrosis does occur in breast tissue, typically following **trauma, surgery, biopsy, or radiation therapy** - Presents as a **painless lump** that can mimic breast cancer on clinical examination and imaging - While common in breast pathology, it is **not the most common cause of fat necrosis overall** when considering systemic pathology - Important differential diagnosis in breast lumps *Incorrect: Omental fat* - Fat necrosis can occur in omental fat, particularly in **omental infarction** or **omental torsion** - Presents with acute abdominal pain and may require surgical intervention - However, this is a relatively **rare condition** compared to pancreatic fat necrosis *Incorrect: None of the options* - This is incorrect because retroperitoneal fat (in the context of acute pancreatitis) is the correct and most common association with fat necrosis

Question 1406: Hypertrophy is -

A. Increase in cell number
B. Increase in cell size (Correct Answer)
C. Decrease in cell number
D. Decrease in cell size

Explanation: ***Increase in cell size*** - **Hypertrophy** is defined as an increase in the **size of individual cells** [1], leading to an increase in the size of the organ or tissue [2]. - This cellular adaptation occurs when cells are subjected to increased workload or demand, such as in **muscle cells** in response to exercise or **cardiac myocytes** in hypertension [2]. *Increase in cell number* - An increase in **cell number** is termed **hyperplasia** [1]. - Hyperplasia typically occurs in tissues capable of **mitotic division**, leading to an increase in the overall size of the tissue or organ due to more cells [1]. *Decrease in cell number* - A decrease in **cell number** can result from **atrophy** (loss of cells) or programmed cell death (**apoptosis**). - This process is seen in various physiological or pathological conditions, leading to a reduction in organ size. *Decrease in cell size* - A decrease in the **size of individual cells** is known as **atrophy** [3]. - Atrophy often occurs due to reduced workload, loss of innervation, diminished blood supply, or inadequate nutrition [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-88. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 45-46. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 90-91.

Question 1407: Which of the following proteins serves as the PRIMARY executioner in the apoptotic pathway by directly cleaving cellular substrates?

A. Caspases (Correct Answer)
B. Cytochrome C
C. Apaf-1
D. Bcl-2

Explanation: ***Caspases*** - **Caspases** are a family of proteases that act as the primary executioners in both the extrinsic and intrinsic apoptotic pathways, directly cleaving various cellular substrates [1]. - Once activated, **executioner caspases** (e.g., caspase-3, -6, -7) dismantle the cell by degrading key structural proteins (lamins, actins), DNA repair enzymes (PARP), and other vital components [1]. - They are the final effectors that lead to the morphological and biochemical changes characteristic of apoptosis [2]. *Apaf-1* - **Apaf-1 (Apoptotic protease activating factor 1)** is an adaptor protein that, upon binding to **cytochrome c**, forms the **apoptosome**. - The **apoptosome** then recruits and activates **initiator caspases** (e.g., caspase-9), which subsequently activate executioner caspases, but Apaf-1 does not directly cleave substrates [3]. - It functions upstream in the pathway as a scaffold protein. *Bcl-2* - **Bcl-2** is an **anti-apoptotic protein** that functions to inhibit apoptosis by preventing the release of pro-apoptotic factors like **cytochrome c** from the mitochondria [4]. - It is a regulator of apoptosis, not an executioner, and does not directly cleave cellular substrates. - It acts by maintaining mitochondrial membrane integrity. *Cytochrome C* - **Cytochrome c** is a mitochondrial intermembrane space protein that, when released into the cytoplasm, acts as a critical signaling molecule for the intrinsic apoptotic pathway [1]. - Upon release, it binds to **Apaf-1** to form the **apoptosome** and activate **caspase-9**; however, it does not directly cleave cellular substrates [2]. - It serves as a pro-apoptotic signal rather than an executioner enzyme. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 65-67. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81.

Question 1408: Reversible change from one cell type to another is known as -

A. Hypertrophy
B. Dysplasia
C. Hyperplasia
D. Metaplasia (Correct Answer)

Explanation: ***Metaplesia*** - Refers to the **reversible change** from one cell type to another in response to chronic irritation or damage [1][2]. - It often occurs as an adaptive response in **epithelial tissues**, such as in the respiratory tract in smokers [1][2]. *Hypertrophy* - Represents an **increase in cell size** rather than a change in cell type [2]. - It is often a response to increased functional demand, as seen in **cardiac muscle** in athletes. *Hyperplesia* - Refers to an **increase in cell number** within a tissue or organ, not a change in cell type [2]. - Common in conditions such as **benign prostatic hyperplasia** but does not involve differentiation into other cell types. *Dysplasia* - Indicates an **abnormal growth or development** of cells, leading to disordered morphology rather than a transformation into another cell type. - It is often a precursor to cancer but does not signify the reversible nature of metaplasia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-92.

Question 1409: During cell death, myelin figures are derived from which of the following?

A. Cell membrane (lipid bilayer) (Correct Answer)
B. Cytoplasmic components
C. Mitochondrial structures
D. Nuclear membrane

Explanation: ***Cell membrane (lipid bilayer)*** - **Myelin figures** are whorled phospholipid masses formed during cell injury and death from the breakdown of **cellular membranes**, particularly the plasma membrane and **endoplasmic reticulum**. - These structures represent damaged membrane lipids (phospholipids) that undergo structural rearrangement into concentric lamellar (layered) configurations resembling myelin. - The term "cell membrane" encompasses both the plasma membrane and lipid-rich intracellular membranes, making this the most accurate answer among the options provided. - They are a characteristic morphologic feature of **irreversible cell injury** and can be seen with electron microscopy. *Cytoplasmic components* - While cytoplasmic proteins and organelles do degrade during cell death, they do not form the organized **phospholipid structures** characteristic of myelin figures. - Cytoplasmic breakdown produces different morphologic changes such as cytoplasmic eosinophilia and loss of ribosomes. *Mitochondrial structures* - Mitochondria have their own membranes that are damaged during cell death (leading to release of cytochrome c and other apoptotic factors). - However, mitochondrial membranes are not the primary source of **myelin figures**, which predominantly arise from ER and plasma membranes. *Nuclear membrane* - The nuclear envelope does fragment during cell death, contributing to nuclear changes like **karyopyknosis, karyorrhexis, and karyolysis**. - While technically a membrane structure, the nuclear envelope is not the primary source of myelin figures, which are mainly derived from the more abundant plasma and ER membranes.

Question 1410: Which type of necrosis is most commonly associated with the spread of infection?

A. Fibrinoid necrosis
B. Fat necrosis
C. Liquefactive necrosis (Correct Answer)
D. Coagulative necrosis

Explanation: ***Liquifactive necrosis*** - Caused by the enzymatic digestion of tissue, leading to the formation of liquid pus, typically associated with bacterial infections [1]. - Commonly occurs in the **brain** and in a tissue impacted by **pyogenic bacteria** [1], demonstrating how infection can lead to tissue damage. *Fat necrosis* - Primarily related to inflammation of fat tissue, often seen in pancreatitis or trauma to fat areas. - It is not directly caused by infections but rather by fat cell damage and necrosis, leading to **saponification**. *Fibrinoid necrosis* - Associated with **immune-mediated vascular injury**, seen in conditions like **vasculitis** or **malignant hypertension** [2]. - Characterized by the deposition of **fibrin-like protein** [2], not directly related to infectious processes. *Coagulative necrosis* - Typically occurs in ischemic conditions like myocardial infarction, where tissue architecture is preserved despite cell death. - It is not directly linked to infection spread, as it relates more to loss of blood supply rather than infectious agents. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 193-194. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 103-104.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free